A Phase 1 Study of S-3304 in Patients With Solid Tumors


Phase 1
18 Years
85 Years
Open (Enrolling)
Both
Solid Tumors

Thank you

Trial Information

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Inclusion Criteria


Inclusion criteria:

- Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)

- Must be able to tolerate oral medication Exclusion criteria

- Patients with other serious illnesses

- Patients who are receiving treatments

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

0110P1416

NCT ID:

NCT00033215

Start Date:

November 2001

Completion Date:

October 2003

Related Keywords:

  • Solid Tumors
  • neovascularization
  • matrix metalloproteinases
  • antiangiogenesis
  • type IV collagenases
  • Neoplasms

Name

Location
Cleveland Clinic Foundation Cleveland, Ohio  44195
Rush-Presbyterian-St. Lukes Medical Center Chicago, Illinois  60612
University of Colorado Hospital Denver, Colorado  80262
Roswell Park Cancer Center Buffalo, New York  14263